Efficus Health
  • Home
  • Services
    • Clinical Development
    • Commercialization
    • Data Science & Analytics
    • Digital/Multi-Channel Marketing & Content Development​
    • Diagnostic Development & Validation
    • Health Economics and Outcomes Research (HEOR)
    • Market Access, Pricing & Reimbursement
    • Medical Affairs
    • Mergers & Acquisitions / Exit options / In or Out Licensing
    • Regulatory Affairs
  • Team
  • Why Efficus
  • Resources
    • Case Studies
    • Insights
    • Videos
  • Contact Us
Select Page
Medical Advisory Boards: Bridging Innovation and Research to the Practicing Community

Medical Advisory Boards: Bridging Innovation and Research to the Practicing Community

by Amit Chhabra | Oct 15, 2025 | Insights

Advisory Boards are where strategy meets science—and life-changing discoveries are forged. If you have a life-saving or life-enhancing innovation (product), a Medical Affairs Advisory Board helps validate its credibility to meet patient and healthcare system needs. In...
Rare Pain Condition Gets Rare FDA Reprieve: Saved Valuable Time and $$$ 

Rare Pain Condition Gets Rare FDA Reprieve: Saved Valuable Time and $$$ 

by Amit Chhabra | Oct 15, 2025 | Case Study

Challenge: A biotech developing a therapy for a rare metabolic bone disease faced regulatory misalignment with FDA pain guidelines, risking costly dual Phase 3 trials.  What We did: Efficus Health crafted an alternative regulatory pathway, engaged directly with...
Driving Credibility: A Comprehensive Publication Strategy for a Medical Device Startup 

Driving Credibility: A Comprehensive Publication Strategy for a Medical Device Startup 

by Amit Chhabra | Oct 14, 2025 | Case Study

Challenge: A biotech developing a high-cost, one-time gene therapy lacked expertise to navigate payer models and reimbursement challenges. What Efficus Health did: Conducted payer research, developed a defensible pricing strategy, and built a roadmap for access and...
De-risking Market Access: A Strategic Pricing and Payer Blueprint for a Gene Therapy 

De-risking Market Access: A Strategic Pricing and Payer Blueprint for a Gene Therapy 

by Amit Chhabra | Oct 14, 2025 | Case Study

Challenge: A biotech developing a high-cost, one-time gene therapy lacked expertise to navigate payer models and reimbursement challenges.  What Efficus Health did: Conducted payer research, developed a defensible pricing strategy, and built a roadmap for access and...
Beyond the Protocol: Designing Patient-Centric Clinical Trials with Cross-Functional Input 

Beyond the Protocol: Designing Patient-Centric Clinical Trials with Cross-Functional Input 

by Amit Chhabra | Oct 14, 2025 | Case Study

Challenge: A biotech designing a pivotal trial sought to reduce patient burden and improve recruitment while aligning with payer and market needs.  What Efficus Health did: Integrated patient insights, advocacy feedback, and cross-functional expertise (Medical...
« Older Entries

Recent Posts

  • Medical Advisory Boards: Bridging Innovation and Research to the Practicing Community
  • Rare Pain Condition Gets Rare FDA Reprieve: Saved Valuable Time and $$$ 
  • Driving Credibility: A Comprehensive Publication Strategy for a Medical Device Startup 
  • De-risking Market Access: A Strategic Pricing and Payer Blueprint for a Gene Therapy 
  • Beyond the Protocol: Designing Patient-Centric Clinical Trials with Cross-Functional Input 

Recent Comments

  1. Paul G Solari on From Academia to Industry – Insights from the Inside 

Archives

  • October 2025
  • May 2025
  • February 2025

Categories

  • Insights
  • Medical Affairs
  • Clinical Development
  • R&D
  • Case Study

Whether you are looking to expand into international markets, launch a new product or enter a new therapeutic area, increase the efficiency of your clinical trials, or better leverage AI and machine learning for drug development, Efficus Health can help your organization lead the way.

Privacy Policy

Loading Comments...